Alpha Dna Investment Management LLC Exact Sciences Corp Transaction History

Alpha Dna Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$59.06 - $75.72 $47,484 - $60,878	-804 Reduced 9.52%	7,645 $565,000
Q3 2023 Nov 07, 2023	SELL	$65.94 - $99.04 $212,392 - $319,007	-3,221 Reduced 27.6%	8,449 $576,000
Q2 2023 Jul 31, 2023	SELL	$62.68 - $95.05 $230,160 - $349,023	-3,672 Reduced 23.93%	11,670 $1.1 Million
Q1 2023 May 05, 2023	BUY	$47.19 - $70.77 $723,988 - $1.09 Million	15,342 New	15,342 $1.04 Million
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $842 - $1,253	-9 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $1,049 - $1,395	9 New	9 $1,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.